KMDA Stock Price, Chart, Stats & News
Kamada Ltd. (KMDA) is a dividend-paying stock with a current dividend yield of 3.43% as of Jul 21, 2026. It pays $0.2500 per share over the trailing twelve months and distributes annually.
Dividend safety
Dividend coverage is moderate for KMDA — it pays out about 71% of earnings.
KMDA chart
Fundamentals
Gross margin | 42.32% |
Operating margin | 14.50% |
Pretax margin | 12.99% |
Net margin | 11.18% |
Effective tax rate | 13.98% |
ROA | 5.35% |
ROE | 7.75% |
D/E | 0.04x |
Interest coverage ratio | 30.26x |
KMDA valuation
P/E | 20.80x |
P/S | 2.59x |
P/B | 1.75x |
P/CF | 18.26x |
P/FCF | 29.73x |
P/OCF | 18.26x |
PEG | -8.35x |
EV multiple | 14.07x |
About
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD).
Related lists
Similar securities
Based on sector and market capitalization
